NeuroOne Medical Technologies Co. (NASDAQ:NMTC) Short Interest Update

NeuroOne Medical Technologies Co. (NASDAQ:NMTC) was the target of a large drop in short interest during the month of April. As of April 15th, there was short interest totalling 308,500 shares, a drop of 15.5% from the March 31st total of 365,300 shares. Based on an average daily trading volume, of 194,700 shares, the days-to-cover ratio is currently 1.6 days. Approximately 1.4% of the company’s shares are sold short.

NeuroOne Medical Technologies Price Performance

Shares of NASDAQ NMTC opened at $1.13 on Friday. The company has a 50 day simple moving average of $1.17 and a 200 day simple moving average of $1.25. The firm has a market cap of $29.30 million, a PE ratio of -1.66 and a beta of 0.81. NeuroOne Medical Technologies has a 1 year low of $0.85 and a 1 year high of $2.00.

NeuroOne Medical Technologies (NASDAQ:NMTC) last issued its quarterly earnings data on Tuesday, February 13th. The company reported ($0.14) earnings per share (EPS) for the quarter. The business had revenue of $0.98 million during the quarter. NeuroOne Medical Technologies had a negative net margin of 478.41% and a negative return on equity of 267.82%.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in NeuroOne Medical Technologies stock. Perkins Capital Management Inc. purchased a new position in shares of NeuroOne Medical Technologies Co. (NASDAQ:NMTC) in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The firm purchased 150,000 shares of the company’s stock, valued at approximately $134,000. Perkins Capital Management Inc. owned about 0.63% of NeuroOne Medical Technologies as of its most recent filing with the SEC. Institutional investors and hedge funds own 16.07% of the company’s stock.

NeuroOne Medical Technologies Company Profile

NeuroOne Medical Technologies Corporation operates as a medical technology company. The company focuses on the development and commercialization of thin film electrode technology for continuous electroencephalogram (cEEG) and stereoelectroencephalography (sEEG) recording, spinal cord stimulation, brain stimulation, and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, chronic pain due to failed back surgeries, and other related neurological disorders.